Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03910660
Title A Trial of BXCL701 and Pembrolizumab in Patients With Small Cell Neuroendocrine Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors BioXcel Therapeutics Inc

prostate neuroendocrine neoplasm

prostate small cell carcinoma


Pembrolizumab + Talabostat mesylate

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.